Liberty Mutual Group Asset Management’s Lifecore Biomedical LFCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q1
Sell
-106,500
Closed -$1.29M 1026
2013
Q4
$1.29M Buy
106,500
+21,320
+25% +$255K 0.05% 662
2013
Q3
$1.04M Sell
85,180
-103,039
-55% -$1.44M 0.04% 570
2013
Q2
$2.49M Buy
+188,219
New +$2.6M 0.1% 260

Other funds holding LFCR

Liberty Mutual Group Asset Management's LFCR Position: Q1 2014 in Review

Liberty Mutual Group Asset Management sold out of Lifecore Biomedical (LFCR) in Q1 2014, closing a stake of 106,500 shares — an estimated $1.29M sold.

Liberty Mutual Group Asset Management first reported a position in LFCR in Q2 2013 and held it in 3 quarters. The position peaked at $2.49M in Q2 2013. 98 funds tracked by Wall St. Rank hold LFCR as of Q1 2014.

  • Liberty Mutual Group Asset Management reported no remaining Lifecore Biomedical position as of Q1 2014 after selling out during the quarter.
  • Liberty Mutual Group Asset Management sold 106,500 Lifecore Biomedical shares in Q1 2014, an estimated $1.29M.
  • Liberty Mutual Group Asset Management first reported a position in Lifecore Biomedical in Q2 2013 and held it in 3 quarters.
  • Liberty Mutual Group Asset Management's Lifecore Biomedical position peaked at $2.49M in Q2 2013.
  • 98 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2014.

Based on Liberty Mutual Group Asset Management's 13F filing for Q1 2014, filed 14 May 2014.